HRA005624
Title:
Pyrotinib in combination with docetaxel as first-line treatment for HER2-positive metastatic breast cancer (PANDORA): a single-arm, multicenter phase 2 trial
Release date:
2023-09-29
Description:
his multicenter, single-arm phase II trial aimed to assess the benefit of pyrotinib plus docetaxel as a first-line treatment for HER2-positive MBC.
Data Accessibility:   
Open access
BioProject:
Study type:
Disease Study
Disease name:
female breast cancer
Dataset Download
MetaData:
Files:
Aspera Command Line:  Help   

 Note: HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client) or Asepra Command Line.

Individuals & samples
Files
Submitter:   Wang Xiaojia / wxiaojia0803@163.com
Organization:   Zhejiang Cancer Hospital
Submission date:   2023-09-23